These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo]. Danner K, Becker HG, Best B, Madler C. Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):425-30. PubMed ID: 11496617 [Abstract] [Full Text] [Related]
3. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Gan TJ, Sinha AC, Kovac AL, Jones RK, Cohen SA, Battikha JP, Deutsch JS, Pergolizzi JV, TDS Study Group, Glass PS. Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328 [Abstract] [Full Text] [Related]
4. [Dolasetron, droperidol and a combination of both in prevention of postoperative nausea and vomiting after extracapsular cataract extraction under general anesthesia]. Eberhart LH, Lindenthal M, Seeling W, Gäckle H, Georgieff M. Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):345-9. PubMed ID: 10429772 [Abstract] [Full Text] [Related]
5. Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study Group. Philip BK, McLeskey CH, Chelly JE, McKenzie R, Kovac AL, Diemunsch P, DuBois DM. J Clin Anesth; 2000 Feb; 12(1):1-8. PubMed ID: 10773500 [Abstract] [Full Text] [Related]
6. A randomized blinded study of the incidence of postoperative nausea and vomiting in women after major gynecologic laparoscopic surgery. Tseng LH, Liou SC, Chang TC, Tsai SC, Soong YK, Wong SY. J Minim Invasive Gynecol; 2006 Feb; 13(5):413-7. PubMed ID: 16962524 [Abstract] [Full Text] [Related]
11. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. Korttila K, Clergue F, Leeser J, Feiss P, Olthoff D, Payeur-Michel C, Wessel P, Nave S, Hahne W, Brown R. Acta Anaesthesiol Scand; 1997 Aug; 41(7):914-22. PubMed ID: 9265937 [Abstract] [Full Text] [Related]
12. Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study. Argiriadou H, Papaziogas B, Pavlidis T, Parlapani A, Georgiou M, Papagiannopoulou P, Papaziogas T. Surg Endosc; 2002 Jul; 16(7):1087-90. PubMed ID: 12165828 [Abstract] [Full Text] [Related]
13. Dolasetron, but not metoclopramide prevents nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Piper SN, Suttner SW, Röhm KD, Maleck WH, Larbig E, Boldt J. Can J Anaesth; 2002 Dec; 49(10):1021-8. PubMed ID: 12477671 [Abstract] [Full Text] [Related]
17. Efficacy and costs of 3 anesthetic regimens in the prevention of postoperative nausea and vomiting. Purhonen S, Koski EM, Niskanen M, Hynynen M. J Clin Anesth; 2006 Feb; 18(1):41-5. PubMed ID: 16517331 [Abstract] [Full Text] [Related]
18. Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group. Diemunsch P, Korttila K, Leeser J, Helmers JH, Wilkey B, Navé S, Radke AJ, Hahne WF, Brown RA. J Clin Anesth; 1998 Mar; 10(2):145-52. PubMed ID: 9524901 [Abstract] [Full Text] [Related]
19. Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures. Browning BA, Fort CA, Kemp KD, Shimata MF, Strube MD. AANA J; 2004 Apr; 72(2):129-32. PubMed ID: 15098526 [Abstract] [Full Text] [Related]
20. Timing of ondansetron administration to prevent postoperative nausea and vomiting. Cruz NI, Portilla P, Vela RE. P R Health Sci J; 2008 Mar; 27(1):43-7. PubMed ID: 18450232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]